Dr. Briccetti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 Pleasant Street
New Hampshire Oncology Hematology Pa
Concord, NH 03301Phone+1 603-224-2556Fax+1 603-226-5821
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1991 - 1994
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1988 - 1991
- University of Cincinnati College of MedicineClass of 1988
Certifications & Licensure
- MA State Medical License 2008 - 2025
- NH State Medical License 1994 - 2024
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2014
Clinical Trials
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab Start of enrollment: 2006 Mar 01
- Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery Start of enrollment: 2006 Feb 01
- Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Start of enrollment: 2008 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsAspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.Wendy Y Chen, Karla V Ballman, Ann H Partridge, Olwen M Hahn, Frederick M Briccetti
JAMA. 2024-05-28 - 74 citationsAdjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical TrialSara M. Tolaney, Nabihah Tayob, Chau T. Dang, Denise A. Yardley, Steven J. Isakoff
Journal of Clinical Oncology. 2021-06-02 - 19 citationsChemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Tr...Kathryn J. Ruddy, Yue Zheng, Nabihah Tayob, Jiani Hu, Chau T. Dang
Breast Cancer Research and Treatment. 2021-06-12
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: